AsclepiX Therapeutics is a biotech company that develops novel therapeutics to revolutionize the treatment of retinal diseases and cancer.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"AsclepiX Therapeutics — Funding & Investors." VCBacked, July 26, 2023, https://www.vcbacked.co/company/asclepix-therapeutics. Accessed June 4, 2026.
VCBacked. (2023). AsclepiX Therapeutics — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/asclepix-therapeutics
{{cite web |title=AsclepiX Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/asclepix-therapeutics |website=VCBacked |access-date=June 4, 2026}}Profile data sourced and verified per the VCBacked methodology. Last funding round dated .